Latest Regulatory Progress News

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Coda Minerals has submitted the Draft Scoping Report for its Elizabeth Creek Copper-Cobalt Project, marking a pivotal step in securing mining lease approvals in South Australia. This milestone reduces regulatory uncertainty and sets a clear path toward project development.

GTi Energy has raised $2.5 million from the first tranche of a $4.5 million placement to fund drilling at its Lo Herma uranium project, with key permits expected in August and a strategic investment from Snow Lake Energy pending shareholder approval.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Imagion Biosystems has received encouraging feedback from the FDA on its planned Phase 2 HER2 breast cancer clinical trial, paving the way for its Investigational New Drug application submission later this year.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Critical Resources Limited has launched a detailed soil-geochemistry survey at its Amoco Gold-Antimony Project in NSW, aiming to sharpen drill targets ahead of planned maiden drilling. Assay results are expected by late August, marking a significant step in advancing exploration within a prolific regional corridor.

Challenger Gold advances its Hualilan Gold Project with final metallurgical testwork underway, confirming heap leach processing can economically recover low-grade gold previously deemed waste. This development promises to expand the project’s scale and improve its economics ahead of the full-scale Pre-Feasibility Study.

Verity Resources has appointed Dr Rick Gordon and Xirlatem Pty Ltd as strategic advisors to accelerate resource upgrades and expansion at its Monument Gold Project in Western Australia.

Manuka Resources has launched a fully underwritten A$8 million entitlement offer to fund the restart of its Wonawinta processing plant and advance its 10-year Cobar Basin Production Plan, targeting silver and gold output by early 2026.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

Medallion Metals reports standout gold and copper assays from Harbour View infill drilling, reinforcing resource confidence ahead of a July update and advancing its strategic Forrestania acquisition.